Cargando…

A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma

PURPOSE: Given that metabolic reprogramming has been recognized as an essential hallmark of cancer cells, this study sought to investigate the potential prognostic values of metabolism-related genes (MRGs) for the diagnosis and treatment of hepatocellular carcinoma (HCC). METHODS: In total, 2752 met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhihao, Embaye, Kidane Siele, Yang, Qing, Qin, Lingzhi, Zhang, Chao, Liu, Liwei, Zhan, Xiaoqian, Zhang, Fengdi, Wang, Xi, Qin, Shenghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981163/ https://www.ncbi.nlm.nih.gov/pubmed/33758763 http://dx.doi.org/10.2147/JHC.S294108

Ejemplares similares

Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma
por: Wang, Zhihao, et al.
Publicado: (2021)

Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes
por: Wang, Zhihao, et al.
Publicado: (2021)

Clinico-pathologic determinants of non-e-curative outcome following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia
por: Embaye, Kidane Siele, et al.
Publicado: (2021)

A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients
por: Wang, Zhihao, et al.
Publicado: (2022)

The Implication of STEP in Synaptic Plasticity and Cognitive Impairments in Alzheimer’s Disease and Other Neurological Disorders
por: Mahaman, Yacoubou Abdoul Razak, et al.
Publicado: (2021)

Distribution of breast lesions diagnosed by cytology examination in symptomatic patients at Eritrean National Health Laboratory, Asmara, Eritrea: a retrospective study
por: Embaye, Kidane Siele, et al.
Publicado: (2020)

Predictors of HIV/AIDS comprehensive knowledge and acceptance attitude towards people living with HIV/AIDS among unmarried young females in Uganda: a cross-sectional study
por: Estifanos, Tesfaldet Mekonnen, et al.
Publicado: (2021)

miR-223 promotes colon cancer by directly targeting p120 catenin
por: Liu, Liwei, et al.
Publicado: (2017)

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma
por: Xiao, Kai, et al.
Publicado: (2020)

p120 Modulates LPS-Induced NF-κB Activation Partially through RhoA in Bronchial Epithelial Cells
por: Qin, Lingzhi, et al.
Publicado: (2014)

Cigarette smoke extract-induced p120-mediated NF-κB activation in human epithelial cells is dependent on the RhoA/ROCK pathway
por: Zhang, Chao, et al.
Publicado: (2016)

Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Shu, Yang, et al.
Publicado: (2022)

Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure
por: Cao, Zhujun, et al.
Publicado: (2015)

An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer
por: Lian, Penghu, et al.
Publicado: (2019)

A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Hui, et al.
Publicado: (2020)

Prognostic Lysosome-Related Biomarkers for Predicting Drug Candidates in Hepatocellular Carcinoma: An Insilco Analysis
por: Xu, Junxiu, et al.
Publicado: (2023)

Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties
por: Cai, Jialin, et al.
Publicado: (2017)

Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma
por: Zhang, Xi, et al.
Publicado: (2021)

Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma
por: He, Aoxiao, et al.
Publicado: (2022)

A Novel Four-Gene Signature as a Potential Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Guangfeng, et al.
Publicado: (2021)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Deng, Zenghua, et al.
Publicado: (2021)

MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma
por: Lu, Haoran, et al.
Publicado: (2023)

A Novel Cuproptosis-Related Signature Identified DLAT as a Prognostic Biomarker for Hepatocellular Carcinoma Patients
por: Bai, Wen Dong, et al.
Publicado: (2022)

Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
por: Li, Baihui, et al.
Publicado: (2021)

A Combined Long Noncoding RNA Signature as a Candidate Prognostic Biomarker for Ovarian Cancer
por: Li, Hui, et al.
Publicado: (2021)

Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma
por: Wang, Jihan, et al.
Publicado: (2021)

Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma
por: Son, Ju A, et al.
Publicado: (2022)

Integrative Analysis of Metallothioneins Identifies MT1H as Candidate Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhang, Feng, et al.
Publicado: (2021)

Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma
por: Ding,, Dongxiao, et al.
Publicado: (2023)

A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2020)

Identification and validation of candidate clinical signatures of apolipoprotein L isoforms in hepatocellular carcinoma
por: Wang, Xiang-Kun, et al.
Publicado: (2023)

A bile acid-related prognostic signature in hepatocellular carcinoma
por: Zhang, Wang, et al.
Publicado: (2022)

Identification of a Prognostic Transcriptome Signature for Hepatocellular Carcinoma with Lymph Node Metastasis
por: Ma, Jie, et al.
Publicado: (2022)

Differentially expressed liver exosome-related genes as candidate prognostic biomarkers for hepatocellular carcinoma
por: Zuo, Bangyou, et al.
Publicado: (2022)

Systematic analyses of a novel lncRNA‐associated signature as the prognostic biomarker for Hepatocellular Carcinoma
por: Sui, Jing, et al.
Publicado: (2018)

A multiomic ferroptosis-associated prognostic signature incorporating epigenetic and transcriptional biomarkers for hepatocellular carcinoma
por: Chen, Jida, et al.
Publicado: (2022)

Immune expression signatures as candidate prognostic biomarkers of age and gender survival differences in cutaneous melanoma
por: Kim, Yi-Jun, et al.
Publicado: (2020)

Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes
por: Duan, Sainan, et al.
Publicado: (2022)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gne9scevbvjinl2s9r5u7vlehv